Financhill
Sell
31

HGV Quote, Financials, Valuation and Earnings

Last price:
$37.35
Seasonality move :
2.88%
Day range:
$36.17 - $37.09
52-week range:
$33.21 - $47.81
Dividend yield:
0%
P/E ratio:
80.51x
P/S ratio:
0.75x
P/B ratio:
1.97x
Volume:
1.2M
Avg. volume:
1.1M
1-year change:
-19.58%
Market cap:
$3.5B
Revenue:
$5B
EPS (TTM):
$0.45

HGV Analysts' Consensus Rating

The 7 analysts providing 12-month price projections for Hilton Grand Vacations shares anticipate an average target of $47.90, ranging from a low estimate of $36.00 to a high estimate of $63.00. This average target implies a growth of 32.21% compared to the current stock price of $36.23.

Consensus Price Target

$47.90

Highest Price Target

$63.00

Lowest Price Target

$36.00

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Analyst Ratings

6M Ago 1M Ago Current
Buy 3 3 3

Hold 3 4 4

Sell 0 0 0
Consensus Leans Bullish Hold Hold

HGV Recommendation Trends

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Alphabet Stock No Longer a Good Bet?
Is Alphabet Stock No Longer a Good Bet?

Alphabet tripled its price per share over the past 5…

Pepsi Vs Coke Stock: Which Is Best?
Pepsi Vs Coke Stock: Which Is Best?

Coca-Cola (NYSE:KO) and PepsiCo (NYSE:PEP) are two of the largest…

Is CyberArk The Next Big Cybersecurity Stock?
Is CyberArk The Next Big Cybersecurity Stock?

CyberArk Software (NASDAQ: CYBR) recently reported phenomenal quarter numbers, passing…

Stock Ideas

Buy
52
Is AAPL Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 35x

Sell
48
Is MSFT Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 33x

Buy
51
Is NVDA Stock a Buy?

Market Cap: $2.8T
P/E Ratio: 39x

Alerts

Sell
49
SRPT alert for Mar 19

Sarepta Therapeutics [SRPT] is up 6.06% over the past day.

Sell
46
CVNA alert for Mar 19

Carvana [CVNA] is up 1.8% over the past day.

Buy
93
ESLT alert for Mar 19

Elbit Systems [ESLT] is down 2.82% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock